Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
Yanzi Cheng,1 Jiwen Zhong,1 Yang Xiang,1 Fan Zeng,1 Dehong Cai,2,† Ling Zhao11Department of Intensive Care Unit, Zhuhai People’s Hospital, Zhuhai, Guangdong, People’s Republic of China; 2Department of Endocrinology, Zhujiang Hospital of Southern Medical University, Gua...
Guardado en:
Autores principales: | Cheng YZ, Zhong JW, Xiang Y, Zeng F, Cai DH, Zhao L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d781020ac97848d991e50457b2d37d37 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fluorescent serum and urinary advanced glycoxidation end-products in non- diabetic subjects
por: DE LA MAZA,MP, et al.
Publicado: (2007) -
Advanced glycation end products and oxidative stress as a basis for metabolic abnormalities in patients with type 1 diabetes after successful simultaneous pancreas-kidney transplantation
por: Irina I. Larina, et al.
Publicado: (2021) -
Transthyretin and Receptor for Advanced Glycation End Product’s Differential Levels Associated with the Pathogenesis of Rheumatoid Arthritis
por: Monu, et al.
Publicado: (2021) -
Inhibitory effect of lotus seedpod oligomeric procyanidins on advanced glycation end product formation in a lactose-lysine model system
por: Wu,Qian, et al.
Publicado: (2015) -
Inhibition of Advanced Glycation End Products in Yogurt by Lotus Seedpod Oligomeric Procyanidin
por: Nianjie Feng, et al.
Publicado: (2021)